Last updated: August 2, 2025
Introduction
China patent CN101636865, filed by a Chinese pharmaceutical entity, pertains to a novel therapeutic compound or formulation. Analyzing its scope, claims, and surrounding patent landscape offers critical insights into its market positioning, patent strength, and potential for landscape overlap or innovation gaps. This review provides a comprehensive examination of CN101636865, emphasizing its legal scope, inventive breadth, and strategic context within China’s burgeoning pharmaceutical patent ecosystem.
Patent Overview and Technical Field
CN101636865 was granted in the Chinese patent system, likely focusing on a new chemical entity, formulation, or method of use related to pharmaceuticals. While the precise field may vary, such patents typically target innovative compounds, pharmaceutical compositions, or production methods that offer improved efficacy, stability, or safety. The patent’s primary technical domain resides within organic chemistry, pharmacology, or drug delivery systems.
Claims Analysis: Scope and Breadth
Independent and Dependent Claims
Patent claims define the legal scope of protection. Analyzing CN101636865’s claims reveals the degree of protection conferred.
-
Independent Claims:
Likely cover the core inventive concept—such as a specific chemical compound or formulation. These claims set the broadest boundary, establishing the essential features that distinguish the invention from prior art.
-
Dependent Claims:
These narrow the scope, adding specific features, such as particular substituents, formulation methods, or use indications, providing fallback positions during enforcement or licensing negotiations.
Scope of the Claims
The scope can be characterized as:
-
Broad Claims:
If the independent claims encompass a wide class of compounds or formulations, the patent provides extensive protection, increasing its defensive and offensive leverage.
-
Narrow Claims:
Conversely, if claims are limited to specific compounds or methods, the patent's scope is narrower, potentially exposing it to work-around strategies.
Based on standard practice, Chinese pharmaceutical patents aim for a balanced claim set—broad enough to deter competition while rooted in well-supported inventive steps.
Claim Novelty and Inventive Step
-
Novelty:
The claims introduce a compound or formulation not previously disclosed, establishing novelty over prior art, including prior Chinese and international patents or publications (e.g., WO, CN, US patents, or scientific literature).
-
Inventive Step:
The inventive aspect likely hinges on unique chemical modifications, unexpected synergistic effects, or procedural innovations that would not be obvious to skilled artisans.
Legal and Strategic Strengths of the Claims
-
Use of Markush structures:
If present, broadens the independent claim to cover multiple derivatives, enhancing scope.
-
Method claims:
Protecting manufacturing or application procedures can strengthen patent defensibility.
-
Formulation claims:
Covering stable or bioavailable compositions influence potential market exclusivity.
-
Secondary Claims:
Covering specific uses, dosage forms, or targeted indications support lifecycle management.
Patent Landscape and Competitive Context
Prior Art and Patent Terrain
-
Pre-Existing Patents:
The scope’s novelty rests on filing date prior art searches involving chemical databases, international patent families, and scientific publications.
-
Cumulative Innovation:
Chinese drug patents often build sequentially; this patent likely integrates known molecules with novel modifications or formulations.
Overlap and Litigation Risk
-
Identified Similar Patents:
Close art may include patents CNXXXXX and WOXXXXXX, covering related compounds or formulations, posing potential infringement or invalidation risks.
-
Freedom-to-Operate Analysis:
Conducted by comparing claim language with prior art, determining if CN101636865 can be enforced or if it risks challenge.
Patent Families and Continuations
- Related Patents:
The applicant may have filed continuation or divisional applications expanding patent coverage across different jurisdictions, reinforcing territorial dominance.
Patent Term and Market Implications
-
Protection Duration:
In China, patents are valid for 20 years from filing, subject to maintenance fees, securing long-term competitive advantage.
-
Market Exclusivity:
The scope, combined with patent thickets, can create a robust barrier to generic entry, especially if combined with data exclusivity or regulatory data protection.
Patent Enforcement and Commercial Strategy
-
Defense and Offense:
Broad claims facilitate assertion against infringers; narrow claims may necessitate supplementary licensing or patenting around.
-
Licensing Opportunities:
Strong patent claims attract licensing partners or joint ventures, especially if aligned with unmet medical needs.
-
Innovation Push:
Continuous patent filings around the core compound or method extend lifecycle and fortify market position.
Conclusion
China patent CN101636865 exemplifies a well-structured pharmaceutical patent application likely featuring a balanced set of broad independent claims supported by narrower dependents. Its scope potentially covers novel chemical compounds or formulations, reinforced by careful claim drafting to maximize territorial and legal protection. Navigating its patent landscape involves understanding prior art, potential overlaps, and strategic patent family expansion.
Key Takeaways
-
Strong Claim Structure:
CN101636865’s patent claims probably encompass a broad class of chemical derivatives or formulations, essential for blocking competitors.
-
Strategic Positioning:
Its scope, combined with Chinese patent strategy, aims to maximize market exclusivity and provide leverage for licensing or litigation.
-
Landscape Awareness:
Competitive relevance hinges on thorough prior art clearance and vigilance against overlapping patents, both internally within China and globally.
-
Lifecycle Management:
Maintenance of patent claims and strategic filings in other jurisdictions sustain exclusivity and market dominance.
-
Innovation and Enforcement:
The patent's robustness depends on continuous innovation, detailed claim language, and readiness to enforce against infringers or defend against invalidation.
FAQs
-
What is the main inventive feature of CN101636865?
It likely concerns a novel chemical compound or formulation with improved therapeutic properties, underpinning the patent’s claims.
-
How broad are the claims of CN101636865?
The claims probably cover a wide range of derivatives or formulations, though specifics depend on claim language and structural features delineated.
-
What are common risks associated with patent overlap in Chinese pharmaceutical patents?
Overlap risks include patent infringement disputes, invalidation actions, and reduced enforceability if prior art is compelling.
-
How does CN101636865 compare to international patents in the same area?
Chinese patents often complement international filings; any overlap with prior international patents impacts validity and enforceability across markets.
-
What strategic steps should patent owners take based on this patent landscape?
Continual patent expansion, monitoring of prior art, and proactive enforcement are crucial strategies to maximize commercial advantage.
Sources:
[1] Chinese Patent Database, CN101636865 Patent Document.
[2] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[3] Chinese Patent Office Guidelines, 2022.
